Deal would create the world’s fourth-largest drugmaker by market value
AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up
Recent Posts
- How should investors position for the robot apocalypse?
- Unpacking the real fiscal costs of immigration
- I’ve covered wine for 50 years. Here are 50 ways it changed
- Investors weigh whether Anthropic can sustain surging revenues post-IPO
- Google’s Gemini agents hacked three companies in new AI safety incident
